BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/25/2020 9:57:11 AM | Browse: 654 | Download: 1452
 |
Received |
|
2020-02-10 09:17 |
|
Peer-Review Started |
|
2020-02-10 09:18 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-03-27 19:14 |
|
Revised |
|
2020-04-18 07:35 |
|
Second Decision |
|
2020-04-23 04:15 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-04-24 01:22 |
|
Articles in Press |
|
2020-04-24 01:22 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-04-25 22:54 |
|
Typeset the Manuscript |
|
2020-05-18 10:59 |
|
Publish the Manuscript Online |
|
2020-05-25 09:57 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Observational Study |
| Article Title |
Serum von Willebrand factor for early diagnosis of lung adenocarcinoma in patients with type 2 diabetes mellitus
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ying-Yi Zhou, Xuan Du, Jia-Li Tang, Qiu-Ping Wang, Ke Chen and Bi-Min Shi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Bi-Min Shi, MD, Academic Research, Department of Endocrinology, The First Affiliated Hospital of Soochow University, No.188 Shizi Road, Suzhou 215000, Jiangsu Province, China. gtmake144523@163.com |
| Key Words |
Type 2 diabetes mellitus; Adenocarcinoma in situ; von Willebrand factor; Early diagnosis; Correlation; |
| Core Tip |
Previous evidence has indicated increased cancer risk among patients with type 2 diabetes mellitus (T2DM). However, early diagnosis of lung adenocarcinoma in situ (AIS) in T2DM patients is difficult, resulting in a lost opportunity for curative-intent surgery in almost 70%‒80% of lung cancer patients. This study revealed that serum levels of von Willebrand factor in patients with T2DM combined with lung AIS were significantly higher than those in patients with T2DM, and thus, can be used to screen lung AIS in T2DM patients. Thus, monitoring serum von Willebrand factor might promote the early diagnosis of lung AIS in T2DM patients. |
| Publish Date |
2020-05-25 09:57 |
| Citation |
Zhou YY, Du X, Tang JL, Wang QP, Chen K, Shi BM. Serum von Willebrand factor for early diagnosis of lung adenocarcinoma in patients with type 2 diabetes mellitus. World J Clin Cases 2020; 8(10): 1916-1922 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i10/1916.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i10.1916 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
